{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:36:26Z","timestamp":1787067386193,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:p>\n                    To investigate the involvement of endogenous opioids in acute increases in blood pressure and their functional relationship with atrial natriuretic factor and endothelin-1, we assessed plasma levels of \u03b2-endorphin, met-enkephalin, dynorphin B, catecholamines, atrial natriuretic factor, and endothelin-1 before and after administration of the opioid antagonist naloxone hydrochloride (8 mg IV) in 28 hypertensive patients with a stress-induced acute increase in blood pressure. Ten patients with established mild or moderate essential hypertension and 10 normotensive subjects served as control groups. Opioids, atrial natriuretic factor, and endothelin-1 were radioimmunoassayed after chromatographic preextraction; catecholamines were determined by high-performance liquid chromatography with electrochemical detection. Patients with an acute increase in blood pressure (systolic, 203.2\u00b12.2 mm Hg; diastolic, 108.4\u00b11.3) had plasma opioid, catecholamine, and atrial natriuretic factor levels significantly (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.01) higher than hypertensive control patients (systolic pressure, 176.4\u00b11.0 mm Hg; diastolic, 100.0\u00b11.4), who had a hormonal pattern similar to that of normotensive subjects (systolic pressure, 123.2\u00b11.5 mm Hg; diastolic, 75.0\u00b12.0). Endothelin-1 did not differ in any group. In patients with an acute increase in blood pressure, naloxone significantly (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.01) reduced blood pressure, heart rate, opioids, catecholamines, and atrial natriuretic factor 10 minutes after administration. Naloxone effects on blood pressure, heart rate, opioids, and catecholamines wore off within 20 minutes. In control groups, naloxone failed to modify any of the considered parameters. Our findings suggest that pressor effects of opioid peptides mediated by the autonomic nervous system during stress-induced acute episodes of blood pressure increase in hypertensive patients.\n                  <\/jats:p>","DOI":"10.1161\/01.hyp.29.1.105","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T20:53:46Z","timestamp":1339448026000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Pressor Effects of Endogenous Opioid System During Acute Episodes of Blood Pressure Increases in Hypertensive Patients"],"prefix":"10.1161","volume":"29","author":[{"given":"Fiorella","family":"Fontana","sequence":"first","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sante","family":"Spampinato","sequence":"additional","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Boschi","sequence":"additional","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"De Iasio","sequence":"additional","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Grossi","sequence":"additional","affiliation":[{"name":"Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","first-page":"H749","volume":"250","year":"1986","unstructured":"Caffrey JL, Wooldridge CB, Gaugl JF. Naloxone enhances myocardial responses to isoproterenol in dog isolated heart-lung. Am J Physiol. 1986;250:H749-H754.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_2_2","first-page":"H416","volume":"239","year":"1980","unstructured":"Curtis MT, Lefer AM. Protective actions of naloxone in hemorrhagic shock. Am J Physiol. 1980;239:H416-H421.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07557.x"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4179(83)90016-1"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0026-895X(25)13810-8","volume":"16","year":"1979","unstructured":"Viveros OH, Diliberto EJ, Hazum E, Chang KJ. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol Pharmacol. 1979;16:1101-1108.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Stock G Schmelz M Knuepfer MM Forssmann WG. Functional and anatomic aspects of central nervous cardiovascular regulation. In: Ganten D Pfaff D eds. Central Cardiovascular Control. New York NY: Springer-Verlag; 1983:1-24.","DOI":"10.1007\/978-3-642-68490-6_1"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(77)90112-5"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(25)33054-5","volume":"221","year":"1982","unstructured":"Gaddis RR, Dixon WR. Modulation of peripheral adrenergic neurotransmission by methionine-enkephalin. J Pharmacol Exp Ther. 1982;221:282-287.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90605-4"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Catlin DH Gorelick DA Gerner RH. Clinical pharmacology of \u03b2-endorphin in depression and schizophrenia. In: Verebey K ed. Opioids in Mental Illness: Theories Clinical Observations and Treatment Possibilities. New York NY: Annals of the New York Academy of Sciences; 1982:434-447.","DOI":"10.1111\/j.1749-6632.1982.tb39515.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199108000-00001"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90800-8"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.9.6.561"},{"key":"e_1_3_1_14_2","unstructured":"Guardigli G Fontana F Ventura C Spagnolo N Bastagli L Puddu P Bernardi P. Endogenous opioids and hypertensive crisis in patients with acute cerebrovascular accident. J Endocrinol Invest. 1989;12(suppl 4):9-12."},{"key":"e_1_3_1_15_2","unstructured":"Weiner H. Personality factors and the importance of emotional stresses in hypertension. In: Genest J Koiw E Kuchel O eds. Hypertension: Physiopathology and Treatment. New York NY: McGraw-Hill Book Co; 1977:661-673."},{"key":"e_1_3_1_16_2","first-page":"108","volume":"66","year":"1995","unstructured":"Leino T, Leppaluoto J, Huttunen P, Ruokonen A, Kuronen P. Neuroendocrine responses to real and simulated BA Hawk MK 51 flight. Aviat Space Environ Med. 1995;66:108-113.","journal-title":"Aviat Space Environ Med"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912143212419"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.2.219"},{"key":"e_1_3_1_19_2","first-page":"1285","volume":"12","year":"1994","unstructured":"Fontana F, Bernardi P, Merlo Pich E, Boschi S, De Iasio R, Capelli M, Carboni L, Spampinato S. Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test. J Hypertens. 1994;12:1285-1290.","journal-title":"J Hypertens"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060316"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)95999-0"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01649022"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.5.1.86"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Esler M Jennings G Biviano B Lambert G Hasking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986;8(suppl 5):S39-S43.","DOI":"10.1097\/00005344-198608005-00008"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.23.040183.002545"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.5.808"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.14.6.636"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000126837"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000126570"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-2-624"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(85)90516-8"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.2.4.395"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90221-3"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245883"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"Martinez JL Jr Schulteis G Weinberger SB. How to increase and decrease the strength of memory traces: the effects of drugs and hormones. In: Martinez JL Jr Kesner RP eds. Learning and Memory A Biological View. New York NY: Academic Press; 1991:149-198.","DOI":"10.1016\/B978-0-12-474993-1.50009-2"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197605000-00008"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.66.6.6291802"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)90131-7"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02396577"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/267495a0"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Naruse M Kawana M Hifumi S Naruse K Yoshihara I Oka T Kato Y Monzen C Kurimoto F Ohsumi K Hosoda S Demura H. Plasma immunoreactive endothelin but not thrombomodulin is increased in patients with essential hypertension and ischemic heart disease. J Cardiovasc Pharmacol. 1991;17(suppl 7):S471-S474.","DOI":"10.1097\/00005344-199100177-00135"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Nava E Luscher F. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. J Hypertens. 1995;13(suppl 2):S39-S48.","DOI":"10.1097\/00004872-199508001-00007"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90543-L"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.15.5.493"},{"key":"e_1_3_1_45_2","first-page":"1127","volume":"321","year":"1990","unstructured":"Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F. Plasma endothelin levels in patients with acute renal failure. N Engl J Med. 1990;321:1127. Letter.","journal-title":"N Engl J Med"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.29.1.105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T17:28:38Z","timestamp":1743355718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.29.1.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1161\/01.HYP.29.1.105"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.29.1.105","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]},"assertion":[{"value":"1996-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-08-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}